Rehmann Capital Advisory Group

Position in JSPR — Jasper Therapeutics, Inc.

CIK 1633037 LANSING, MI

Position in JSPR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$13,402

New position

Shares Held

15,300

first reported quarter

Ownership

0.055%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Rehmann Capital Advisory Group holds $2,772,824 across 3 Biotechnology names. JSPR ranks #3 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	2,393	$1,848,927
2	VRTX	Vertex Pharmaceuticals Inc / Ma	2,039	$910,495
3	JSPR	Jasper Therapeutics, Inc. This page	15,300	$13,402

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$13,402	15,300	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.